CVS Group Plc, a UK listed veterinary group and provider of veterinary services, has announced the exercise of options over 107,903 new Ordinary shares of 0.2 pence each. The options were exercised under the CVS Group 2020 Long Term Incentive Plan by various employees, including the Chief Executive Officer, Deputy CEO, and Chief Financial Officer. Additionally, the CVS Group Employee Benefit Trust (EBT) purchased 56,896 of the new shares from option-holders to meet the costs of exercise incurred by certain individuals. The EBT is a discretionary trust for the benefit of the company's employees, including the directors. The purchase of the new shares by the EBT was funded from the company's existing cash reserves. Following this transaction, the EBT holds a total of 57,280 Ordinary shares, representing approximately 0.08% of the company's total voting rights. The new shares rank pari passu with the company's existing Ordinary shares and were admitted to the London Stock Exchange on 15 May 2023. The total number of voting rights in the company is now 71,537,662. The Executive Directors, together with their respective spouses, hold a beneficial interest in a certain number of Ordinary shares in the company.